Annual SGA
$21.06 M
+$13.96 M+196.38%
December 1, 2023
Summary
- As of February 7, 2025, CATX annual SGA is $21.06 million, with the most recent change of +$13.96 million (+196.38%) on December 1, 2023.
- During the last 3 years, CATX annual SGA has risen by +$13.93 million (+195.39%).
- CATX annual SGA is now -30.08% below its all-time high of $30.13 million, reached on June 1, 2005.
Performance
CATX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$6.97 M
+$1.46 M+26.50%
September 1, 2024
Summary
- As of February 7, 2025, CATX quarterly SGA is $6.97 million, with the most recent change of +$1.46 million (+26.50%) on September 1, 2024.
- Over the past year, CATX quarterly SGA has increased by +$2.50 million (+55.90%).
- CATX quarterly SGA is now at all-time high.
Performance
CATX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$685.14 M
-$63.78 M-10.27%
September 1, 2024
Summary
- As of February 7, 2025, CATX TTM SGA is -$685.14 million, with the most recent change of -$63.78 million (-10.27%) on September 1, 2024.
- Over the past year, CATX TTM SGA has dropped by -$701.27 million (-4349.21%).
- CATX TTM SGA is now -13006.24% below its all-time high of -$5.23 million.
Performance
CATX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CATX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +196.4% | +55.9% | -4349.2% |
| 3 y3 years | +195.4% | +4.7% | -5447.2% |
| 5 y5 years | +207.5% | +4.7% | -5447.2% |
CATX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +196.4% | at high | +211.9% | -122.8% | at low |
| 5 y | 5-year | at high | +207.5% | at high | +323.2% | -122.8% | at low |
| alltime | all time | -30.1% | >+9999.0% | at high | >+9999.0% | <-9999.0% | at low |
Perspective Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $6.97 M(+26.5%) | $23.31 M(+12.0%) |
| Jun 2024 | - | $5.51 M(-6.2%) | $20.81 M(+2.6%) |
| Mar 2024 | - | $5.88 M(+19.0%) | $20.28 M(-3.7%) |
| Dec 2023 | $21.06 M(+196.4%) | $4.94 M(+10.4%) | $21.06 M(+30.6%) |
| Sep 2023 | - | $4.47 M(-10.3%) | $16.12 M(+3.6%) |
| Jun 2023 | - | $4.99 M(-25.2%) | $15.56 M(+21.5%) |
| Mar 2023 | - | $6.66 M(+70.2%) | $12.81 M(+19.3%) |
| Dec 2022 | $7.11 M(-24.6%) | - | - |
| Sep 2022 | - | $3.91 M(+75.0%) | $10.74 M(+13.9%) |
| Jun 2022 | - | $2.24 M(-1.4%) | $9.43 M(+2.9%) |
| Jun 2022 | $9.43 M(+32.2%) | - | - |
| Mar 2022 | - | $2.27 M(-2.2%) | $9.16 M(+5.8%) |
| Dec 2021 | - | $2.32 M(-10.8%) | $8.66 M(+7.1%) |
| Sep 2021 | - | $2.60 M(+32.0%) | $8.08 M(+13.4%) |
| Jun 2021 | $7.13 M(-5.5%) | - | - |
| Jun 2021 | - | $1.97 M(+11.7%) | $7.13 M(+0.5%) |
| Mar 2021 | - | $1.76 M(+0.9%) | $7.10 M(-2.7%) |
| Dec 2020 | - | $1.75 M(+6.1%) | $7.29 M(+0.2%) |
| Sep 2020 | - | $1.65 M(-15.0%) | $7.28 M(-3.5%) |
| Jun 2020 | $7.55 M(+10.2%) | $1.94 M(-1.1%) | $7.55 M(+3.5%) |
| Mar 2020 | - | $1.96 M(+12.8%) | $7.29 M(+3.1%) |
| Dec 2019 | - | $1.74 M(-9.2%) | $7.08 M(-0.9%) |
| Sep 2019 | - | $1.91 M(+13.7%) | $7.14 M(+4.2%) |
| Jun 2019 | $6.85 M(+0.4%) | $1.68 M(-3.6%) | $6.85 M(-7.5%) |
| Mar 2019 | - | $1.74 M(-3.3%) | $7.40 M(+3.8%) |
| Dec 2018 | - | $1.80 M(+11.2%) | $7.13 M(+2.1%) |
| Sep 2018 | - | $1.62 M(-27.4%) | $6.99 M(+2.4%) |
| Jun 2018 | $6.83 M(+9.6%) | $2.23 M(+51.5%) | $6.82 M(+2.8%) |
| Mar 2018 | - | $1.48 M(-11.1%) | $6.64 M(+1.8%) |
| Dec 2017 | - | $1.66 M(+14.0%) | $6.52 M(+4.5%) |
| Sep 2017 | - | $1.46 M(-29.0%) | $6.23 M(+0.1%) |
| Jun 2017 | $6.23 M(+21.2%) | $2.05 M(+51.1%) | $6.23 M(+9.3%) |
| Mar 2017 | - | $1.35 M(-1.5%) | $5.70 M(+2.6%) |
| Dec 2016 | - | $1.38 M(-5.2%) | $5.56 M(-0.1%) |
| Sep 2016 | - | $1.45 M(-4.5%) | $5.56 M(+8.2%) |
| Jun 2016 | $5.14 M(+32.1%) | $1.52 M(+25.4%) | $5.14 M(+7.7%) |
| Mar 2016 | - | $1.21 M(-12.2%) | $4.77 M(+5.4%) |
| Dec 2015 | - | $1.38 M(+33.9%) | $4.53 M(+13.5%) |
| Sep 2015 | - | $1.03 M(-10.7%) | $3.99 M(+2.6%) |
| Jun 2015 | $3.89 M(+4.5%) | $1.15 M(+19.5%) | $3.89 M(+4.0%) |
| Mar 2015 | - | $964.80 K(+14.6%) | $3.74 M(+3.2%) |
| Dec 2014 | - | $841.70 K(-9.5%) | $3.62 M(+0.0%) |
| Sep 2014 | - | $929.70 K(-7.5%) | $3.62 M(-2.2%) |
| Jun 2014 | $3.72 M(+3.7%) | $1.00 M(+18.6%) | $3.70 M(+1.5%) |
| Mar 2014 | - | $847.40 K(+0.8%) | $3.65 M(-0.7%) |
| Dec 2013 | - | $840.40 K(-16.8%) | $3.67 M(-0.4%) |
| Sep 2013 | - | $1.01 M(+6.3%) | $3.69 M(+1.4%) |
| Jun 2013 | $3.59 M(+0.6%) | $950.70 K(+8.8%) | $3.64 M(-0.4%) |
| Mar 2013 | - | $873.60 K(+2.0%) | $3.66 M(+1.1%) |
| Dec 2012 | - | $856.60 K(-10.9%) | $3.62 M(+1.6%) |
| Sep 2012 | - | $960.90 K(-0.6%) | $3.56 M(-0.2%) |
| Jun 2012 | $3.57 M(-2.3%) | $967.00 K(+15.8%) | $3.57 M(+1.2%) |
| Mar 2012 | - | $834.80 K(+4.2%) | $3.53 M(-0.8%) |
| Dec 2011 | - | $801.30 K(-17.2%) | $3.56 M(-2.6%) |
| Sep 2011 | - | $967.30 K(+4.5%) | $3.65 M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | $3.66 M(-16.8%) | $925.90 K(+7.3%) | $3.66 M(-5.8%) |
| Mar 2011 | - | $862.80 K(-3.8%) | $3.88 M(-4.5%) |
| Dec 2010 | - | $896.80 K(-7.5%) | $4.06 M(-6.0%) |
| Sep 2010 | - | $969.60 K(-15.7%) | $4.32 M(-1.7%) |
| Jun 2010 | $4.39 M(-14.8%) | $1.15 M(+10.2%) | $4.39 M(+1.8%) |
| Mar 2010 | - | $1.04 M(-9.5%) | $4.32 M(-3.4%) |
| Dec 2009 | - | $1.15 M(+10.4%) | $4.47 M(-4.8%) |
| Sep 2009 | - | $1.05 M(-2.5%) | $4.69 M(-9.0%) |
| Jun 2009 | $5.16 M(-29.3%) | $1.07 M(-10.4%) | $5.16 M(-7.8%) |
| Mar 2009 | - | $1.20 M(-13.3%) | $5.60 M(-9.1%) |
| Dec 2008 | - | $1.38 M(-8.7%) | $6.16 M(-10.0%) |
| Sep 2008 | - | $1.51 M(-0.0%) | $6.84 M(-6.2%) |
| Jun 2008 | $7.29 M(-12.1%) | $1.51 M(-14.0%) | $7.29 M(-10.8%) |
| Mar 2008 | - | $1.76 M(-14.7%) | $8.18 M(-0.4%) |
| Dec 2007 | - | $2.06 M(+5.1%) | $8.21 M(+4.5%) |
| Sep 2007 | - | $1.96 M(-18.1%) | $7.86 M(-5.4%) |
| Jun 2007 | $8.30 M(+68.6%) | $2.39 M(+34.0%) | $8.30 M(+11.1%) |
| Mar 2007 | - | $1.79 M(+4.4%) | $7.47 M(+10.7%) |
| Dec 2006 | - | $1.71 M(-28.9%) | $6.75 M(+11.5%) |
| Sep 2006 | - | $2.41 M(+53.5%) | $6.05 M(+23.0%) |
| Jun 2006 | $4.92 M(-83.7%) | $1.57 M(+47.3%) | $4.92 M(+46.7%) |
| Mar 2006 | - | $1.06 M(+4.8%) | $3.36 M(+46.3%) |
| Dec 2005 | - | $1.02 M(-20.4%) | $2.29 M(+79.0%) |
| Sep 2005 | - | $1.28 M(>+9900.0%) | $1.28 M(+7102.8%) |
| Jun 2005 | $30.13 M(>+9900.0%) | - | - |
| Mar 2005 | - | $2500.00(-30.6%) | $17.80 K(+5.3%) |
| Dec 2004 | - | $3600.00(-14.3%) | $16.90 K(-29.9%) |
| Sep 2004 | $9100.00(-52.1%) | $4200.00(-44.0%) | $24.10 K(-10.4%) |
| Jun 2004 | - | $7500.00(+368.8%) | $26.90 K(+26.9%) |
| Mar 2004 | - | $1600.00(-85.2%) | $21.20 K(-4.9%) |
| Dec 2003 | - | $10.80 K(+54.3%) | $22.30 K(+16.8%) |
| Sep 2003 | $19.00 K(+150.0%) | $7000.00(+288.9%) | $19.10 K(+61.9%) |
| Jun 2003 | - | $1800.00(-33.3%) | $11.80 K(+2.6%) |
| Mar 2003 | - | $2700.00(-64.5%) | $11.50 K(-16.1%) |
| Dec 2002 | - | $7600.00(-2633.3%) | $13.70 K(+80.3%) |
| Sep 2002 | $7600.00(-51.3%) | -$300.00(-120.0%) | $7600.00(-20.8%) |
| Jun 2002 | - | $1500.00(-69.4%) | $9600.00(-49.5%) |
| Mar 2002 | - | $4900.00(+226.7%) | $19.00 K(+25.8%) |
| Dec 2001 | - | $1500.00(-11.8%) | $15.10 K(-3.8%) |
| Sep 2001 | $15.60 K(+0.6%) | $1700.00(-84.4%) | $15.70 K(+12.1%) |
| Jun 2001 | - | $10.90 K(+990.0%) | $14.00 K(+351.6%) |
| Mar 2001 | - | $1000.00(-52.4%) | $3100.00(+47.6%) |
| Dec 2000 | - | $2100.00(>+9900.0%) | $2100.00(-83.3%) |
| Jun 2000 | - | $0.00(0.0%) | $12.60 K(-5.3%) |
| Mar 2000 | - | $0.00(0.0%) | $13.30 K(-3.6%) |
| Dec 1999 | - | $0.00(-100.0%) | $13.80 K(-16.4%) |
| Sep 1999 | $15.50 K(-93.0%) | $12.60 K(+1700.0%) | $16.50 K(+323.1%) |
| Jun 1999 | - | $700.00(+40.0%) | $3900.00(+21.9%) |
| Mar 1999 | - | $500.00(-81.5%) | $3200.00(+18.5%) |
| Dec 1998 | - | $2700.00 | $2700.00 |
| Sep 1998 | $221.90 K(-25.5%) | - | - |
| Sep 1997 | $297.90 K(-88.5%) | - | - |
| Sep 1996 | $2.59 M(+108.2%) | - | - |
| Sep 1995 | $1.24 M(+1.3%) | - | - |
| Sep 1994 | $1.23 M | - | - |
FAQ
- What is Perspective Therapeutics annual SGA?
- What is the all time high annual SGA for Perspective Therapeutics?
- What is Perspective Therapeutics annual SGA year-on-year change?
- What is Perspective Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly SGA year-on-year change?
- What is Perspective Therapeutics TTM SGA?
- What is the all time high TTM SGA for Perspective Therapeutics?
- What is Perspective Therapeutics TTM SGA year-on-year change?
What is Perspective Therapeutics annual SGA?
The current annual SGA of CATX is $21.06 M
What is the all time high annual SGA for Perspective Therapeutics?
Perspective Therapeutics all-time high annual SGA is $30.13 M
What is Perspective Therapeutics annual SGA year-on-year change?
Over the past year, CATX annual SGA has changed by +$13.96 M (+196.38%)
What is Perspective Therapeutics quarterly SGA?
The current quarterly SGA of CATX is $6.97 M
What is the all time high quarterly SGA for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly SGA is $6.97 M
What is Perspective Therapeutics quarterly SGA year-on-year change?
Over the past year, CATX quarterly SGA has changed by +$2.50 M (+55.90%)
What is Perspective Therapeutics TTM SGA?
The current TTM SGA of CATX is -$685.14 M
What is the all time high TTM SGA for Perspective Therapeutics?
Perspective Therapeutics all-time high TTM SGA is -$5.23 M
What is Perspective Therapeutics TTM SGA year-on-year change?
Over the past year, CATX TTM SGA has changed by -$701.27 M (-4349.21%)